{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:57:07Z","timestamp":1791309427308,"version":"4.3.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00428-025-04267-3","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:19:13Z","timestamp":1761286753000},"page":"943-957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrative diagnostic approach to salivary gland tumors: from clinical evaluation to molecularly targeted therapy"],"prefix":"10.1007","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-8051","authenticated-orcid":false,"given":"Anna Lu\u00edza Damaceno","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reydson Alcides","family":"de Lima-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Viviane","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vander Poorten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Stenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Agustin","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Roger","family":"Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"de Castro J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Ferrarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Sk\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Ferlito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Paulo","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"4267_CR1","unstructured":"WHO Classification of Tumours Editorial Board (2022) Head and Neck Tumours, 5th ed. International Agency for Research on Cancer, Lyon (France)"},{"key":"4267_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.path.2016.04.002","volume":"9","author":"RR Seethala","year":"2016","unstructured":"Seethala RR, Griffith CC (2016) Molecular pathology: predictive, prognostic, and diagnostic markers in salivary gland tumors. Surg Pathol Clin 9:339\u2013352","journal-title":"Surg Pathol Clin"},{"key":"4267_CR3","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","volume":"42","author":"A Sk\u00e1lov\u00e1","year":"2018","unstructured":"Sk\u00e1lov\u00e1 A, Stenman G, Simpson RHW et al (2018) The role of molecular testing in the differential diagnosis of salivary gland carcinomas. Am J Surg Pathol 42:e11\u2013e27. https:\/\/doi.org\/10.1097\/PAS.0000000000000980","journal-title":"Am J Surg Pathol"},{"key":"4267_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.5858\/arpa.2022-0461-RA","volume":"147","author":"MA Swid","year":"2023","unstructured":"Swid MA, Li L, Drahnak EM et al (2023) Updated salivary gland immunohistochemistry: a review. Arch Pathol Lab Med 147:1383\u20131389. https:\/\/doi.org\/10.5858\/arpa.2022-0461-RA","journal-title":"Arch Pathol Lab Med"},{"key":"4267_CR5","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.3390\/cancers13153910","volume":"13","author":"J Iyer","year":"2021","unstructured":"Iyer J, Hariharan A, Cao UMN et al (2021) An overview on the histogenesis and morphogenesis of salivary gland neoplasms and evolving diagnostic approaches. Cancers (Basel) 13:3910. https:\/\/doi.org\/10.3390\/cancers13153910","journal-title":"Cancers (Basel)"},{"key":"4267_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cncy.22814","volume":"132","author":"SN Freiberger","year":"2024","unstructured":"Freiberger SN, Ikenberg K, van Egmond D et al (2024) Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: an exploratory multicenter study. Cancer Cytopathol 132:435\u2013446. https:\/\/doi.org\/10.1002\/cncy.22814","journal-title":"Cancer Cytopathol"},{"key":"4267_CR7","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.jcms.2018.09.028","volume":"46","author":"LP da Silva","year":"2018","unstructured":"da Silva LP, Serpa MS, Viveiros SK et al (2018) Salivary gland tumors in a Brazilian population: a 20-year retrospective and multicentric study of 2292 cases. Journal of Cranio-Maxillofacial Surgery 46:2227\u20132233. https:\/\/doi.org\/10.1016\/j.jcms.2018.09.028","journal-title":"Journal of Cranio-Maxillofacial Surgery"},{"key":"4267_CR8","doi-asserted-by":"crossref","unstructured":"Bishop JA; Thompson LDR; Wakely PE Jr; Weinreb I (2021) Tumors of the Salivary Glands. In: Montgomery EA (ed) AFIP Atlas of Tumor and Non-Tumor Pathology, 5th series. American Registry of Pathology, Arlington, VA","DOI":"10.55418\/9781933477947"},{"key":"4267_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/jop.13151","volume":"50","author":"BVR Louredo","year":"2021","unstructured":"Louredo BVR, Santos-Silva AR, Vargas PA et al (2021) Clinicopathological analysis and survival outcomes of primary salivary gland tumors in pediatric patients: a systematic review. J Oral Pathol Med 50:435\u2013443. https:\/\/doi.org\/10.1111\/jop.13151","journal-title":"J Oral Pathol Med"},{"key":"4267_CR10","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.26983","author":"M-E P\u00e9rez-de-Oliveira","year":"2025","unstructured":"P\u00e9rez-de-Oliveira M-E, Sousa-Neto S-S, Vargas P-A (2025) Epithelial salivary gland neoplasms in pediatric patients: A comprehensive review. Med Oral Patol Oral Cir Bucal. https:\/\/doi.org\/10.4317\/medoral.26983","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"4267_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01535","author":"S Peeperkorn","year":"2020","unstructured":"Peeperkorn S, Meulemans J, Van Lierde C et al (2020) Validated prognostic nomograms for patients with parotid carcinoma predicting 2- and 5-year tumor recurrence-free interval probability. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.01535","journal-title":"Front Oncol"},{"key":"4267_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","volume":"74","author":"M Guzzo","year":"2010","unstructured":"Guzzo M, Locati LD, Prott FJ et al (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134\u2013148. https:\/\/doi.org\/10.1016\/j.critrevonc.2009.10.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"4267_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s12105-022-01459-0","volume":"16","author":"I Alsanie","year":"2022","unstructured":"Alsanie I, Rajab S, Cottom H et al (2022) Distribution and frequency of salivary gland tumours: an international multicenter study. Head Neck Pathol 16:1043\u20131054. https:\/\/doi.org\/10.1007\/s12105-022-01459-0","journal-title":"Head Neck Pathol"},{"key":"4267_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bjoms.2012.10.002","volume":"51","author":"PJ Bradley","year":"2013","unstructured":"Bradley PJ, McGurk M (2013) Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg 51:399\u2013403. https:\/\/doi.org\/10.1016\/j.bjoms.2012.10.002","journal-title":"Br J Oral Maxillofac Surg"},{"key":"4267_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11912-022-01356-3","volume":"25","author":"PF Moretz-sohn","year":"2023","unstructured":"Moretz-sohn PF, Dias FL, de Carvalho Marques CM (2023) Minor salivary gland cancer of the head and neck: a review of epidemiologic aspects, prognostic factors, and outcomes. Curr Oncol Rep 25:173\u2013179. https:\/\/doi.org\/10.1007\/s11912-022-01356-3","journal-title":"Curr Oncol Rep"},{"key":"4267_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hed.28132","author":"L Lavareze","year":"2025","unstructured":"Lavareze L, Kimura TdeC, Cacita N et al (2025) Survival outcomes in adenoid cystic carcinoma of the head and neck: a systematic review of 17 497 cases and meta-analysis. Head Neck. https:\/\/doi.org\/10.1002\/hed.28132","journal-title":"Head Neck"},{"key":"4267_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04141-2","author":"A Sk\u00e1lov\u00e1","year":"2025","unstructured":"Sk\u00e1lov\u00e1 A, Bradov\u00e1 M, Laco J et al (2025) Basal cell adenoma with S100 protein\u2013positive \u201cstroma\u201d: a distinct triphasic salivary gland neoplasm characterized by CTNNB1 mutation. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-025-04141-2","journal-title":"Virchows Arch"},{"key":"4267_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00428-023-03504-x","volume":"482","author":"A Agaimy","year":"2023","unstructured":"Agaimy A, Mantsopoulos K, Iro H, Stoehr R (2023) KRAS codon 12 mutations characterize a subset of de novo proliferating \u201cmetaplastic\u201d Warthin tumors. Virchows Arch 482:839\u2013848. https:\/\/doi.org\/10.1007\/s00428-023-03504-x","journal-title":"Virchows Arch"},{"key":"4267_CR19","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/biomedicines10081970","volume":"10","author":"G Stenman","year":"2022","unstructured":"Stenman G, Fehr A, Sk\u00e1lov\u00e1 A et al (2022) Chromosome translocations, gene fusions, and their molecular consequences in pleomorphic salivary gland adenomas. Biomedicines 10:1970. https:\/\/doi.org\/10.3390\/biomedicines10081970","journal-title":"Biomedicines"},{"key":"4267_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00428-024-03798-5","volume":"485","author":"PJ Bradley","year":"2024","unstructured":"Bradley PJ, Stenman G, Thompson LDR et al (2024) Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland. Virchows Arch 485:3\u201311. https:\/\/doi.org\/10.1007\/s00428-024-03798-5","journal-title":"Virchows Arch"},{"key":"4267_CR21","doi-asserted-by":"publisher","unstructured":"Lydiatt WM, Patel SG, O\u2019Sullivan B, et al (2017) Head and neck cancers\u2014major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67:122\u2013137. https:\/\/doi.org\/10.3322\/caac.21389","DOI":"10.3322\/caac.21389"},{"key":"4267_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12105-009-0102-9","volume":"3","author":"RR Seethala","year":"2009","unstructured":"Seethala RR (2009) An update on grading of salivary gland carcinomas. Head Neck Pathol 3:69\u201377. https:\/\/doi.org\/10.1007\/s12105-009-0102-9","journal-title":"Head Neck Pathol"},{"key":"4267_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/his.14322","volume":"79","author":"JC Hernandez-Prera","year":"2021","unstructured":"Hernandez-Prera JC, Sk\u00e1lov\u00e1 A, Franchi A et al (2021) Pleomorphic adenoma: the great mimicker of malignancy. Histopathology 79:279\u2013290. https:\/\/doi.org\/10.1111\/his.14322","journal-title":"Histopathology"},{"key":"4267_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-04015-z","author":"RA de Lima-Souza","year":"2025","unstructured":"de Lima-Souza RA, B\u011blohl\u00e1vkov\u00e1 K, Michal M et al (2025) Atypical and worrisome histological features in pleomorphic adenoma: challenging and potentially significant diagnostic pitfall. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-024-04015-z","journal-title":"Virchows Arch"},{"key":"4267_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/PAP.0000000000000298","volume":"28","author":"A Skalova","year":"2021","unstructured":"Skalova A, Leivo I, Hellquist H et al (2021) High-grade transformation\/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance. Adv Anat Pathol 28:107\u2013118. https:\/\/doi.org\/10.1097\/PAP.0000000000000298","journal-title":"Adv Anat Pathol"},{"key":"4267_CR26","doi-asserted-by":"publisher","first-page":"104494","DOI":"10.1016\/j.critrevonc.2024.104494","volume":"204","author":"RA de Lima-Souza","year":"2024","unstructured":"de Lima-Souza RA, de Vieira GS, de Kimura TC et al (2024) Insights into the molecular alterations of PLAG1 and HMGA2 associated with malignant phenotype acquisition in pleomorphic adenoma. Crit Rev Oncol Hematol 204:104494. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104494","journal-title":"Crit Rev Oncol Hematol"},{"key":"4267_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.humpath.2020.07.009","volume":"103","author":"M Ban\u011b\u010dkov\u00e1","year":"2020","unstructured":"Ban\u011b\u010dkov\u00e1 M, Uro-Coste E, Pt\u00e1kov\u00e1 N et al (2020) What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases. Hum Pathol 103:52\u201362. https:\/\/doi.org\/10.1016\/j.humpath.2020.07.009","journal-title":"Hum Pathol"},{"key":"4267_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng0297-170","volume":"15","author":"K Kas","year":"1997","unstructured":"Kas K, Voz ML, R\u00f6ijer E et al (1997) Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet 15:170\u2013174. https:\/\/doi.org\/10.1038\/ng0297-170","journal-title":"Nat Genet"},{"key":"4267_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s12105-019-01088-0","volume":"14","author":"JA Bishop","year":"2020","unstructured":"Bishop JA, Gagan J, Baumhoer D et al (2020) Sclerosing Polycystic \u201cAdenosis\u201d of Salivary Glands: A Neoplasm Characterized by PI3K Pathway Alterations More Correctly Named Sclerosing Polycystic Adenoma. Head Neck Pathol 14:630\u2013636. https:\/\/doi.org\/10.1007\/s12105-019-01088-0","journal-title":"Head Neck Pathol"},{"key":"4267_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/PAS.0000000000001807","volume":"46","author":"A Sk\u00e1lov\u00e1","year":"2022","unstructured":"Sk\u00e1lov\u00e1 A, Ban\u011b\u010dkov\u00e1 M, Laco J et al (2022) Sclerosing polycystic adenoma of salivary glands. Am J Surg Pathol 46:268\u2013280. https:\/\/doi.org\/10.1097\/PAS.0000000000001807","journal-title":"Am J Surg Pathol"},{"key":"4267_CR31","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/hed.27435","volume":"45","author":"T de Carvalho Kimura","year":"2023","unstructured":"de Carvalho Kimura T, de Lima-Souza RA, Scarini JF et al (2023) Clinicopathological profile of sclerosing polycystic adenoma\/adenosis: a systematic review. Head Neck 45:2449\u20132457. https:\/\/doi.org\/10.1002\/hed.27435","journal-title":"Head Neck"},{"key":"4267_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12105-016-0730-9","volume":"10","author":"TC Wilson","year":"2016","unstructured":"Wilson TC, Ma D, Tilak A et al (2016) Next-generation sequencing in salivary gland basal cell adenocarcinoma and basal cell adenoma. Head Neck Pathol 10:494\u2013500. https:\/\/doi.org\/10.1007\/s12105-016-0730-9","journal-title":"Head Neck Pathol"},{"key":"4267_CR33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/PAS.0000000000000669","volume":"40","author":"VY Jo","year":"2016","unstructured":"Jo VY, Sholl LM, Krane JF (2016) Distinctive patterns of CTNNB1 (\u03b2-catenin) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am J Surg Pathol 40:1143\u20131150. https:\/\/doi.org\/10.1097\/PAS.0000000000000669","journal-title":"Am J Surg Pathol"},{"key":"4267_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.prp.2017.12.016","volume":"214","author":"M Sato","year":"2018","unstructured":"Sato M, Yamamoto H, Hatanaka Y et al (2018) Wnt\/\u03b2-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Pathol Res Pract 214:586\u2013592. https:\/\/doi.org\/10.1016\/j.prp.2017.12.016","journal-title":"Pathol Res Pract"},{"key":"4267_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41379-018-0018-6","volume":"31","author":"M Rito","year":"2018","unstructured":"Rito M, Mitani Y, Bell D et al (2018) Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression. Mod Pathol 31:1064\u20131072. https:\/\/doi.org\/10.1038\/s41379-018-0018-6","journal-title":"Mod Pathol"},{"key":"4267_CR36","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1038\/s41467-025-59871-3","volume":"16","author":"K Wong","year":"2025","unstructured":"Wong K, Bishop JA, Weinreb I et al (2025) Wnt\/\u03b2-catenin activation by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary basal cell adenoma. Nat Commun 16:4657. https:\/\/doi.org\/10.1038\/s41467-025-59871-3","journal-title":"Nat Commun"},{"key":"4267_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12105-022-01513-x","volume":"17","author":"AC McLean","year":"2022","unstructured":"McLean AC, Rooper LM, Gagan J et al (2022) A subset of salivary intercalated duct lesions harbors recurrent CTNNB1 and HRAS mutations: a molecular link to basal cell adenoma and epithelial-myoepithelial carcinoma? Head Neck Pathol 17:393\u2013400. https:\/\/doi.org\/10.1007\/s12105-022-01513-x","journal-title":"Head Neck Pathol"},{"key":"4267_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/PAS.0000000000002004","volume":"47","author":"LM Rooper","year":"2023","unstructured":"Rooper LM, Agaimy A, Assaad A et al (2023) Recurrent IDH2 mutations in salivary gland striated duct adenoma define an expanded histologic spectrum distinct from canalicular adenoma. Am J Surg Pathol 47:333\u2013343. https:\/\/doi.org\/10.1097\/PAS.0000000000002004","journal-title":"Am J Surg Pathol"},{"key":"4267_CR39","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1097\/PAS.0000000000001080","volume":"42","author":"A Agaimy","year":"2018","unstructured":"Agaimy A, Mueller SK, Bumm K et al (2018) Intraductal papillary mucinous neoplasms of minor salivary glands with AKT1 p.Glu17Lys mutation. Am J Surg Pathol 42:1076\u20131082. https:\/\/doi.org\/10.1097\/PAS.0000000000001080","journal-title":"Am J Surg Pathol"},{"key":"4267_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12105-019-01068-4","volume":"14","author":"M-S Hsieh","year":"2020","unstructured":"Hsieh M-S, Bishop JA, Wang Y-P et al (2020) Salivary sialadenoma papilliferum consists of two morphologically, immunophenotypically, and genetically distinct subtypes. Head Neck Pathol 14:489\u2013496. https:\/\/doi.org\/10.1007\/s12105-019-01068-4","journal-title":"Head Neck Pathol"},{"key":"4267_CR41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/modpathol.3800379","volume":"18","author":"M Arida","year":"2005","unstructured":"Arida M, Barnes EL, Hunt JL (2005) Molecular assessment of allelic loss in Warthin tumors. Mod Pathol 18:964\u2013968. https:\/\/doi.org\/10.1038\/modpathol.3800379","journal-title":"Mod Pathol"},{"key":"4267_CR42","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0046-8177(00)80007-6","volume":"31","author":"K Honda","year":"2000","unstructured":"Honda K, Kashima K, Daa T et al (2000) Clonal analysis of the epithelial component of Warthin\u2019s tumor. Hum Pathol 31:1377\u20131380","journal-title":"Hum Pathol"},{"key":"4267_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-4608(90)90006-v","volume":"46","author":"J Mark","year":"1990","unstructured":"Mark J, Dahlenfors R, Stenman G, Nordquist A (1990) Chromosomal patterns in Warthin\u2019s tumor. A second type of human benign salivary gland neoplasm. Cancer Genet Cytogenet 46:35\u201339. https:\/\/doi.org\/10.1016\/0165-4608(90)90006-v","journal-title":"Cancer Genet Cytogenet"},{"key":"4267_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0165-4608(94)90463-4","volume":"76","author":"A Nordkvist","year":"1994","unstructured":"Nordkvist A, Mark J, Dahlenfors R et al (1994) Cytogenetic observations in 13 cystadenolymphomas (Warthin\u2019s tumors). Cancer Genet Cytogenet 76:129\u2013135. https:\/\/doi.org\/10.1016\/0165-4608(94)90463-4","journal-title":"Cancer Genet Cytogenet"},{"key":"4267_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/his.13990","volume":"76","author":"M Nakaguro","year":"2020","unstructured":"Nakaguro M, Urano M, Ogawa I et al (2020) Histopathological evaluation of minor salivary gland papillary\u2013cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm. Histopathology 76:411\u2013422. https:\/\/doi.org\/10.1111\/his.13990","journal-title":"Histopathology"},{"key":"4267_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tripleo.2008.11.018","volume":"107","author":"L Gallego","year":"2009","unstructured":"Gallego L, Junquera L, Fresno MF (2009) Non-sebaceous lymphadenoma of the parotid gland: immunohistochemical study and DNA ploidy analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:555\u2013558. https:\/\/doi.org\/10.1016\/j.tripleo.2008.11.018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"4267_CR47","doi-asserted-by":"publisher","DOI":"10.3892\/or.1.3.561","author":"J Mark","year":"1994","unstructured":"Mark J, Dahlenfors R, Wedell B et al (1994) Cytogenetical and FISH analysis on a salivary sebaceous lymphadenoma. Oncol Rep. https:\/\/doi.org\/10.3892\/or.1.3.561","journal-title":"Oncol Rep"},{"key":"4267_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/PAS.0000000000002169","volume":"48","author":"JA Bishop","year":"2024","unstructured":"Bishop JA, Nakaguro M, Urano M et al (2024) Keratocystoma. Am J Surg Pathol 48:317\u2013328. https:\/\/doi.org\/10.1097\/PAS.0000000000002169","journal-title":"Am J Surg Pathol"},{"key":"4267_CR49","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/jop.12970","volume":"49","author":"ME P\u00e9rez-de-Oliveira","year":"2020","unstructured":"P\u00e9rez-de-Oliveira ME, Wagner VP, Ara\u00fajo ALD et al (2020) Prognostic value of CRTC1-MAML2 translocation in salivary mucoepidermoid carcinoma: systematic review and meta-analysis. J Oral Pathol Med 49:386\u2013394. https:\/\/doi.org\/10.1111\/jop.12970","journal-title":"J Oral Pathol Med"},{"key":"4267_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/gcc.23020","volume":"61","author":"A Sk\u00e1lov\u00e1","year":"2022","unstructured":"Sk\u00e1lov\u00e1 A, Hyrcza MD, Vane\u010dek T et al (2022) Fusion-positive salivary gland carcinomas. Genes Chromosomes Cancer 61:228\u2013243. https:\/\/doi.org\/10.1002\/gcc.23020","journal-title":"Genes Chromosomes Cancer"},{"key":"4267_CR51","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.1073\/pnas.0909114106","volume":"106","author":"M Persson","year":"2009","unstructured":"Persson M, Andr\u00e9n Y, Mark J et al (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 106:18740\u201318744. https:\/\/doi.org\/10.1073\/pnas.0909114106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4267_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136771","volume":"22","author":"MT Meyer","year":"2021","unstructured":"Meyer MT, Watermann C, Dreyer T et al (2021) 2021 update on diagnostic markers and translocation in salivary gland tumors. Int J Mol Sci 22:6771. https:\/\/doi.org\/10.3390\/ijms22136771","journal-title":"Int J Mol Sci"},{"key":"4267_CR53","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/his.13281","volume":"71","author":"K Fujii","year":"2017","unstructured":"Fujii K, Murase T, Beppu S et al (2017) MYBL 1, MYBL, 2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma. Histopathology 71:823\u2013834. https:\/\/doi.org\/10.1111\/his.13281","journal-title":"Histopathology"},{"key":"4267_CR54","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1172\/JCI67201","volume":"123","author":"PJ Stephens","year":"2013","unstructured":"Stephens PJ, Davies HR, Mitani Y et al (2013) Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest 123:2965\u20132968. https:\/\/doi.org\/10.1172\/JCI67201","journal-title":"J Clin Invest"},{"key":"4267_CR55","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1172\/JCI128227","volume":"129","author":"AS Ho","year":"2019","unstructured":"Ho AS, Ochoa A, Jayakumaran G et al (2019) Genetic hallmarks of recurrent\/metastatic adenoid cystic carcinoma. J Clin Invest 129:4276\u20134289. https:\/\/doi.org\/10.1172\/JCI128227","journal-title":"J Clin Invest"},{"key":"4267_CR56","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","volume":"27","author":"R Ferrarotto","year":"2023","unstructured":"Ferrarotto R, Mitani Y, McGrail DJ et al (2023) Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets. Clin Cancer Res 27:852\u2013864. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1192","journal-title":"Clin Cancer Res"},{"key":"4267_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/cncy.21959","volume":"126","author":"S Andreasen","year":"2018","unstructured":"Andreasen S, Melchior LC, Kiss K et al (2018) The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA. Cancer Cytopathol 126:275\u2013281. https:\/\/doi.org\/10.1002\/cncy.21959","journal-title":"Cancer Cytopathol"},{"key":"4267_CR58","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/PAS.0000000000001431","volume":"44","author":"B Xu","year":"2020","unstructured":"Xu B, Barbieri AL, Bishop JA et al (2020) Histologic classification and molecular signature of polymorphous adenocarcinoma (PAC) and cribriform adenocarcinoma of salivary gland (CASG). Am J Surg Pathol 44:545\u2013552. https:\/\/doi.org\/10.1097\/PAS.0000000000001431","journal-title":"Am J Surg Pathol"},{"key":"4267_CR59","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41467-018-08069-x","volume":"10","author":"F Haller","year":"2019","unstructured":"Haller F, Bieg M, Will R et al (2019) Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun 10:368. https:\/\/doi.org\/10.1038\/s41467-018-08069-x","journal-title":"Nat Commun"},{"key":"4267_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/PAS.0000000000001200","volume":"43","author":"S Andreasen","year":"2019","unstructured":"Andreasen S, Varma S, Barasch N et al (2019) The HTN3-MSANTD3 fusion gene defines a subset of acinic cell carcinoma of the salivary gland. Am J Surg Pathol 43:489\u2013496. https:\/\/doi.org\/10.1097\/PAS.0000000000001200","journal-title":"Am J Surg Pathol"},{"key":"4267_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171265","volume":"12","author":"N Barasch","year":"2017","unstructured":"Barasch N, Gong X, Kwei KA et al (2017) Recurrent rearrangements of the Myb\/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma. PLoS ONE 12:e0171265. https:\/\/doi.org\/10.1371\/journal.pone.0171265","journal-title":"PLoS ONE"},{"key":"4267_CR62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","volume":"34","author":"A Sk\u00e1lov\u00e1","year":"2010","unstructured":"Sk\u00e1lov\u00e1 A, Vanecek T, Sima R et al (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34:599\u2013608. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d9efcc","journal-title":"Am J Surg Pathol"},{"key":"4267_CR63","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/PAS.0000000000002043","volume":"47","author":"M Ban\u011b\u010dkov\u00e1","year":"2023","unstructured":"Ban\u011b\u010dkov\u00e1 M, Thompson LDR, Hyrcza MD et al (2023) Salivary gland secretory carcinoma. Am J Surg Pathol 47:661\u2013677. https:\/\/doi.org\/10.1097\/PAS.0000000000002043","journal-title":"Am J Surg Pathol"},{"key":"4267_CR64","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/PAS.0000000000001273","volume":"43","author":"JA Bishop","year":"2019","unstructured":"Bishop JA, Weinreb I, Swanson D et al (2019) Microsecretory adenocarcinoma. Am J Surg Pathol 43:1023\u20131032. https:\/\/doi.org\/10.1097\/PAS.0000000000001273","journal-title":"Am J Surg Pathol"},{"key":"4267_CR65","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s12105-021-01331-7","volume":"15","author":"JA Bishop","year":"2021","unstructured":"Bishop JA, Sajed DP, Weinreb I et al (2021) Microsecretory adenocarcinoma of salivary glands: an expanded series of 24 cases. Head Neck Pathol 15:1192\u20131201. https:\/\/doi.org\/10.1007\/s12105-021-01331-7","journal-title":"Head Neck Pathol"},{"key":"4267_CR66","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/PAS.0000000000001980","volume":"47","author":"I Weinreb","year":"2023","unstructured":"Weinreb I, Hahn E, Dickson BC et al (2023) Microcribriform adenocarcinoma of salivary glands. Am J Surg Pathol 47:194\u2013201. https:\/\/doi.org\/10.1097\/PAS.0000000000001980","journal-title":"Am J Surg Pathol"},{"key":"4267_CR67","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/gcc.20881","volume":"50","author":"CR Antonescu","year":"2011","unstructured":"Antonescu CR, Katabi N, Zhang L et al (2011) EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 50:559\u2013570. https:\/\/doi.org\/10.1002\/gcc.20881","journal-title":"Genes Chromosomes Cancer"},{"key":"4267_CR68","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/PAS.0000000000001114","volume":"42","author":"E Chapman","year":"2018","unstructured":"Chapman E, Skalova A, Ptakova N et al (2018) Molecular profiling of hyalinizing clear cell carcinomas revealed a subset of tumors harboring a novel EWSR1-CREM fusion. Am J Surg Pathol 42:1182\u20131189. https:\/\/doi.org\/10.1097\/PAS.0000000000001114","journal-title":"Am J Surg Pathol"},{"key":"4267_CR69","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/PAS.0000000000000952","volume":"42","author":"I Weinreb","year":"2018","unstructured":"Weinreb I, Bishop JA, Chiosea SI et al (2018) Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland. Am J Surg Pathol 42:442\u2013452. https:\/\/doi.org\/10.1097\/PAS.0000000000000952","journal-title":"Am J Surg Pathol"},{"key":"4267_CR70","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/PAS.0000000000001301","volume":"43","author":"A Sk\u00e1lov\u00e1","year":"2019","unstructured":"Sk\u00e1lov\u00e1 A, Pt\u00e1kov\u00e1 N, Santana T et al (2019) NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors. Am J Surg Pathol 43:1303\u20131313. https:\/\/doi.org\/10.1097\/PAS.0000000000001301","journal-title":"Am J Surg Pathol"},{"key":"4267_CR71","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","volume":"22","author":"MG Dalin","year":"2016","unstructured":"Dalin MG, Desrichard A, Katabi N et al (2016) Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer. Clin Cancer Res 22:4623\u20134633. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0637","journal-title":"Clin Cancer Res"},{"key":"4267_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100766","volume":"38","author":"Y Utsumi","year":"2025","unstructured":"Utsumi Y, Nakaguro M, Kawakita D et al (2025) Cytoplasmic p53 immunostaining in salivary duct carcinoma: a poor prognostic factor associated with characteristic TP53 variants. Mod Pathol 38:100766. https:\/\/doi.org\/10.1016\/j.modpat.2025.100766","journal-title":"Mod Pathol"},{"key":"4267_CR73","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/PAS.0000000000002307","volume":"48","author":"RA de Lima-Souza","year":"2024","unstructured":"de Lima-Souza RA, Altemani A, Michal M et al (2024) Expanding the molecular spectrum of carcinoma ex pleomorphic adenoma. Am J Surg Pathol 48:1491\u20131502. https:\/\/doi.org\/10.1097\/PAS.0000000000002307","journal-title":"Am J Surg Pathol"},{"key":"4267_CR74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.humpath.2019.08.009","volume":"93","author":"T Santana","year":"2019","unstructured":"Santana T, Pavel A, Martinek P et al (2019) Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Hum Pathol 93:37\u201347. https:\/\/doi.org\/10.1016\/j.humpath.2019.08.009","journal-title":"Hum Pathol"},{"key":"4267_CR75","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/PAS.0000000000001698","volume":"45","author":"A Agaimy","year":"2021","unstructured":"Agaimy A, Ban\u011b\u010dkov\u00e1 M, Ihrler S et al (2021) ALK rearrangements characterize 2 distinct types of salivary gland carcinomas. Am J Surg Pathol 45:1166\u20131178. https:\/\/doi.org\/10.1097\/PAS.0000000000001698","journal-title":"Am J Surg Pathol"},{"key":"4267_CR76","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/jop.13395","volume":"52","author":"L Lavareze","year":"2023","unstructured":"Lavareze L, Scarini JF, de Lima-Souza RA et al (2023) Clinicopathological and survival profile of patients with salivary gland myoepithelial carcinoma: a systematic review. J Oral Pathol Med 52:101\u2013108. https:\/\/doi.org\/10.1111\/jop.13395","journal-title":"J Oral Pathol Med"},{"key":"4267_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00428-025-04120-7","volume":"487","author":"H Yagi","year":"2025","unstructured":"Yagi H, Utsumi Y, Tada Y et al (2025) Correlation between basal cell adenoma and basal cell adenocarcinoma of the salivary gland: a histomorphological and molecular review of 129 cases. Virchows Arch 487:75\u201386. https:\/\/doi.org\/10.1007\/s00428-025-04120-7","journal-title":"Virchows Arch"},{"key":"4267_CR78","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-024-01661-2","volume":"18","author":"JPG de Paiva","year":"2024","unstructured":"de Paiva JPG, Rold\u00e1n DG, Bezerra HKF et al (2024) Intraoral salivary gland cystadenomas: a case series study and literature review. Head Neck Pathol 18:45. https:\/\/doi.org\/10.1007\/s12105-024-01661-2","journal-title":"Head Neck Pathol"},{"key":"4267_CR79","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13000-021-01084-5","volume":"16","author":"S Chen","year":"2021","unstructured":"Chen S, Peng J, Yuan C et al (2021) Sialadenoma papilliferum: clinicopathologic, immunohistochemical, molecular analyses of new five cases and review of the literature. Diagn Pathol 16:22. https:\/\/doi.org\/10.1186\/s13000-021-01084-5","journal-title":"Diagn Pathol"},{"key":"4267_CR80","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/PAI.0000000000000222","volume":"24","author":"AA Owosho","year":"2016","unstructured":"Owosho AA, Aguilar CE, Seethala RR (2016) Comparison of p63 and p40 (\u0394Np63) as basal, squamoid, and myoepithelial markers in salivary gland tumors. Appl Immunohistochem Mol Morphol 24:501\u2013508. https:\/\/doi.org\/10.1097\/PAI.0000000000000222","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"4267_CR81","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12105-012-0403-2","volume":"7","author":"RN Sams","year":"2013","unstructured":"Sams RN, Gnepp DR (2013) P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol 7:64\u201368. https:\/\/doi.org\/10.1007\/s12105-012-0403-2","journal-title":"Head Neck Pathol"},{"key":"4267_CR82","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/hed.26081","volume":"42","author":"K Ueda","year":"2020","unstructured":"Ueda K, Murase T, Nagao T et al (2020) Central pathology review of salivary gland adenoid cystic carcinoma. Head Neck 42:1721\u20131727. https:\/\/doi.org\/10.1002\/hed.26081","journal-title":"Head Neck"},{"key":"4267_CR83","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00405-018-4985-5","volume":"275","author":"V Vander Poorten","year":"2018","unstructured":"Vander Poorten V, Triantafyllou A, Sk\u00e1lov\u00e1 A et al (2018) Polymorphous adenocarcinoma of the salivary glands: reappraisal and update. Eur Arch Otorhinolaryngol 275:1681\u20131695. https:\/\/doi.org\/10.1007\/s00405-018-4985-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4267_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/apm.70008","author":"A Paiva-Correia","year":"2025","unstructured":"Paiva-Correia A, Hellquist H, Apol\u00f3nio J, Castelo-Branco P (2025) Role of ancillary techniques in the differential diagnosis of salivary gland carcinomas. APMIS. https:\/\/doi.org\/10.1111\/apm.70008","journal-title":"APMIS"},{"key":"4267_CR85","doi-asserted-by":"publisher","first-page":"580141","DOI":"10.3389\/fonc.2020.580141","volume":"10","author":"L Di Villeneuve","year":"2020","unstructured":"Di Villeneuve L, Souza IL, Tolentino FDS et al (2020) Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease. Front Oncol 10:580141. https:\/\/doi.org\/10.3389\/fonc.2020.580141","journal-title":"Front Oncol"},{"key":"4267_CR86","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ijc.31353","volume":"143","author":"E Boon","year":"2018","unstructured":"Boon E, Bel M, van Boxtel W et al (2018) A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from <scp>T<\/scp> he <scp>N<\/scp> etherlands. Int J Cancer 143:758\u2013766. https:\/\/doi.org\/10.1002\/ijc.31353","journal-title":"Int J Cancer"},{"key":"4267_CR87","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/PAS.0000000000001688","volume":"45","author":"LM Rooper","year":"2021","unstructured":"Rooper LM, Argyris PP, Thompson LDR et al (2021) Salivary mucinous adenocarcinoma is a histologically diverse single entity with recurrent AKT1 E17K mutations. Am J Surg Pathol 45:1337\u20131347. https:\/\/doi.org\/10.1097\/PAS.0000000000001688","journal-title":"Am J Surg Pathol"},{"key":"4267_CR88","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12105-015-0670-9","volume":"10","author":"IV Neelakantan","year":"2016","unstructured":"Neelakantan IV, Di Palma S, Smith CET, McCoombe A (2016) Parotid sebaceous carcinoma in patient with Muir Torre syndrome, caused by MSH2 mutation. Head Neck Pathol 10:354\u2013361. https:\/\/doi.org\/10.1007\/s12105-015-0670-9","journal-title":"Head Neck Pathol"},{"key":"4267_CR89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/CCO.0000000000000280","volume":"28","author":"R Ferrarotto","year":"2016","unstructured":"Ferrarotto R, Heymach JV, Glisson BS (2016) MYB-fusions and other potential actionable targets in adenoid cystic carcinoma. Curr Opin Oncol 28:195\u2013200. https:\/\/doi.org\/10.1097\/CCO.0000000000000280","journal-title":"Curr Opin Oncol"},{"key":"4267_CR90","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1200\/JCO.2016.67.5264","volume":"35","author":"R Ferrarotto","year":"2017","unstructured":"Ferrarotto R, Mitani Y, Diao L et al (2017) Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors. J Clin Oncol 35:352\u2013360. https:\/\/doi.org\/10.1200\/JCO.2016.67.5264","journal-title":"J Clin Oncol"},{"key":"4267_CR91","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","volume":"12","author":"SA Laurie","year":"2011","unstructured":"Laurie SA, Ho AL, Fury MG et al (2011) Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 12:815\u2013824. https:\/\/doi.org\/10.1016\/S1470-2045(10)70245-X","journal-title":"Lancet Oncol"},{"key":"4267_CR92","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.18.01859","volume":"37","author":"V Tchekmedyian","year":"2019","unstructured":"Tchekmedyian V, Sherman EJ, Dunn L et al (2019) Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma. J Clin Oncol 37:1529\u20131537. https:\/\/doi.org\/10.1200\/JCO.18.01859","journal-title":"J Clin Oncol"},{"key":"4267_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103886","volume":"181","author":"VP Wagner","year":"2023","unstructured":"Wagner VP, Ferrarotto R, Vargas PA et al (2023) Drug-based therapy for advanced adenoid cystic carcinoma: current landscape and challenges based on an overview of registered clinical trials. Crit Rev Oncol Hematol 181:103886. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103886","journal-title":"Crit Rev Oncol Hematol"},{"key":"4267_CR94","unstructured":"EU Clinical Trials Register. EUCT number: 2023\u2013508476\u201311\u201300. Available at: https:\/\/euclinicaltrials.eu\/ctis-public\/view\/2023-508476-11-00"},{"key":"4267_CR95","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1158\/1078-0432.CCR-23-0514","volume":"29","author":"LG Sousa","year":"2023","unstructured":"Sousa LG, McGrail DJ, Lazar Neto F et al (2023) Spatial immunoprofiling of adenoid cystic carcinoma reveals B7\u2013H4 is a therapeutic target for aggressive tumors. Clin Cancer Res 29:3162\u20133171. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0514","journal-title":"Clin Cancer Res"},{"key":"4267_CR96","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1200\/JCO.2025.43.16_suppl.3009","volume":"43","author":"EP Hamilton","year":"2025","unstructured":"Hamilton EP, Han HS, Kalinsky K et al (2025) Initial phase 1 dose escalation data for emiltatug ledadotin (Emi-Le), a novel B7\u2013H4-directed dolasynthen antibody-drug conjugate. J Clin Oncol 43:3009\u20133009. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.3009","journal-title":"J Clin Oncol"},{"key":"4267_CR97","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/annonc\/mdy171","volume":"29","author":"R Ferrarotto","year":"2018","unstructured":"Ferrarotto R, Eckhardt G, Patnaik A et al (2018) A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. Ann Oncol 29:1561\u20131568. https:\/\/doi.org\/10.1093\/annonc\/mdy171","journal-title":"Ann Oncol"},{"key":"4267_CR98","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41419-022-05133-9","volume":"13","author":"R Ferrarotto","year":"2022","unstructured":"Ferrarotto R, Mishra V, Herz E et al (2022) AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling. Cell Death Dis 13:678. https:\/\/doi.org\/10.1038\/s41419-022-05133-9","journal-title":"Cell Death Dis"},{"key":"4267_CR99","doi-asserted-by":"publisher","unstructured":"Kieran R, de Paula BHR, Hubank M, et al (2021) Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat. JCO Precis Oncol 1579\u20131583. https:\/\/doi.org\/10.1200\/PO.21.00228","DOI":"10.1200\/PO.21.00228"},{"key":"4267_CR100","doi-asserted-by":"publisher","unstructured":"Hoff CO, Dal Lago EA, Siqueira JM, et al (2024) First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.23.00633","DOI":"10.1200\/PO.23.00633"},{"key":"4267_CR101","doi-asserted-by":"publisher","unstructured":"Locati LD, Ferrarotto R, Licitra L, et al (2023) Current management and future challenges in salivary glands cancer. Front Oncol 13:. https:\/\/doi.org\/10.3389\/fonc.2023.1264287","DOI":"10.3389\/fonc.2023.1264287"},{"key":"4267_CR102","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1200\/JCO.2005.06.125","volume":"23","author":"SJ Hotte","year":"2005","unstructured":"Hotte SJ, Winquist EW, Lamont E et al (2005) Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 23:585\u2013590. https:\/\/doi.org\/10.1200\/JCO.2005.06.125","journal-title":"J Clin Oncol"},{"key":"4267_CR103","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.oraloncology.2005.12.026","volume":"43","author":"MR Pfeffer","year":"2007","unstructured":"Pfeffer MR, Talmi Y, Catane R et al (2007) A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol 43:33\u201336. https:\/\/doi.org\/10.1016\/j.oraloncology.2005.12.026","journal-title":"Oral Oncol"},{"key":"4267_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100602","volume":"7","author":"C van Herpen","year":"2022","unstructured":"van Herpen C, Vander Poorten V, Skalova A et al (2022) Salivary gland cancer: ESMO\u2013European reference network on rare adult solid cancers (EURACAN) clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open 7:100602. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100602","journal-title":"ESMO Open"},{"key":"4267_CR105","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5114\/wo.2023.131204","volume":"27","author":"M Durzy\u0144ska","year":"2023","unstructured":"Durzy\u0144ska M, Dominiak K, Sosnowska I, Michalek IM (2023) Secretory carcinoma of major and minor salivary glands with ETV6-NTRK3 gene fusion: overcoming misdiagnosis in the era of tumour-agnostic therapy with TRK inhibitors. Wspolczesna Onkol 27:101\u2013108. https:\/\/doi.org\/10.5114\/wo.2023.131204","journal-title":"Wspolczesna Onkol"},{"key":"4267_CR106","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac080","author":"X Le","year":"2022","unstructured":"Le X, Baik C, Bauman J et al (2022) Larotrectinib treatment for patients with TRK fusion-positive salivary gland cancers. Oncologist. https:\/\/doi.org\/10.1093\/oncolo\/oyac080","journal-title":"Oncologist"},{"key":"4267_CR107","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12920-022-01155-6","volume":"15","author":"K Suzuki","year":"2022","unstructured":"Suzuki K, Harada H, Takeda M et al (2022) Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report. BMC Med Genomics 15:6. https:\/\/doi.org\/10.1186\/s12920-022-01155-6","journal-title":"BMC Med Genomics"},{"key":"4267_CR108","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sj.bjc.6605788","volume":"103","author":"B Lujan","year":"2010","unstructured":"Lujan B, Hakim S, Moyano S et al (2010) Activation of the EGFR\/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. Br J Cancer 103:510\u2013516. https:\/\/doi.org\/10.1038\/sj.bjc.6605788","journal-title":"Br J Cancer"},{"key":"4267_CR109","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3109\/00016489.2016.1170876","volume":"136","author":"K Nakano","year":"2016","unstructured":"Nakano K, Sato Y, Sasaki T et al (2016) Combination chemotherapy of carboplatin and paclitaxel for advanced\/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses. Acta Otolaryngol 136:948\u2013951. https:\/\/doi.org\/10.3109\/00016489.2016.1170876","journal-title":"Acta Otolaryngol"},{"key":"4267_CR110","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdx771","volume":"29","author":"C Fushimi","year":"2018","unstructured":"Fushimi C, Tada Y, Takahashi H et al (2018) A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol 29:979\u2013984. https:\/\/doi.org\/10.1093\/annonc\/mdx771","journal-title":"Ann Oncol"},{"key":"4267_CR111","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/14737140.2023.2208350","volume":"23","author":"M Wotman","year":"2023","unstructured":"Wotman M, El-Naggar A, Ferrarotto R (2023) Targeting human EGFR 2 (HER2) in salivary gland carcinoma. Expert Rev Anticancer Ther 23:573\u2013582. https:\/\/doi.org\/10.1080\/14737140.2023.2208350","journal-title":"Expert Rev Anticancer Ther"},{"key":"4267_CR112","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.2017.75.3780","volume":"36","author":"JD Hainsworth","year":"2018","unstructured":"Hainsworth JD, Meric-Bernstam F, Swanton C et al (2018) Targeted therapy for advanced solid tumors on the basis of molecular profiles: results from MyPathway, an open-label, phase IIa multiple basket study. J Clin Oncol 36:536\u2013542. https:\/\/doi.org\/10.1200\/JCO.2017.75.3780","journal-title":"J Clin Oncol"},{"key":"4267_CR113","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1200\/JCO.18.00545","volume":"37","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Tada Y, Saotome T et al (2019) Phase II trial of Trastuzumab and Docetaxel in patients with human epidermal growth factor receptor 2\u2013positive salivary duct carcinoma. J Clin Oncol 37:125\u2013134. https:\/\/doi.org\/10.1200\/JCO.18.00545","journal-title":"J Clin Oncol"},{"key":"4267_CR114","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1634\/theoncologist.2012-0369","volume":"18","author":"SA Limaye","year":"2013","unstructured":"Limaye SA, Posner MR, Krane JF et al (2013) Trastuzumab for the treatment of salivary duct carcinoma. Oncologist 18:294\u2013300. https:\/\/doi.org\/10.1634\/theoncologist.2012-0369","journal-title":"Oncologist"},{"key":"4267_CR115","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/hed.25468","volume":"41","author":"G Schvartsman","year":"2019","unstructured":"Schvartsman G, Pinto NA, Bell D, Ferrarotto R (2019) Salivary gland tumors: molecular characterization and therapeutic advances for metastatic disease. Head Neck 41:239\u2013247. https:\/\/doi.org\/10.1002\/hed.25468","journal-title":"Head Neck"},{"key":"4267_CR116","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/cncy.22288","volume":"128","author":"M Nakaguro","year":"2020","unstructured":"Nakaguro M, Tada Y, Faquin WC et al (2020) Salivary duct carcinoma: updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol 128:693\u2013703. https:\/\/doi.org\/10.1002\/cncy.22288","journal-title":"Cancer Cytopathol"}],"updated-by":[{"DOI":"10.1007\/s00428-025-04347-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000}}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04267-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:55:13Z","timestamp":1764248113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04267-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4267"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04267-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00428-025-04347-4","URL":"https:\/\/doi.org\/10.1007\/s00428-025-04347-4","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Does not apply.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"AA is Editor-in-Chief of Virchows Archiv. AS serves on the editorial board of Virchows Archiv.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the authors used ChatGPT (Mar 14 version) from OpenAI (\n                      \n                      ) in order to specifically review grammar and spelling. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. No large language models\/tool\/ service were used to analyze and draw insights from data as part of the research process.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted technologies in the writing process"}},{"value":"Does not apply.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing and data accessibility statement"}}]}}